Clik here to view.
San Diego’s Fight Against Diabesity: Can Investors Make Money, and Can...
Luke Timmerman San Diego might be the world’s leading center for “diabesity” R&D, and since this represents two of the most common public health threats today (diabetes and obesity), logic would...
View ArticleClik here to view.
How Can San Diego Win the Fight Against Diabesity? Xconomy to Dig Deep on...
Luke Timmerman One of San Diego’s strengths as a biotech hub is its expertise fighting two of the biggest epidemics of the 21st century—obesity and diabetes. Yet the FDA has taken a tough stance,...
View ArticleClik here to view.
See You Tonight at “San Diego’s Fight Against Diabesity”
Luke Timmerman If two-thirds of all Americans are too heavy, and millions more continue to get diabetes, how will we pay the trillions in medical bills over the next decade? Who will find ways to...
View ArticleClik here to view.
Sofinnova Ventures Defies the Grim Mood, Raises $440M For Biotech-Only VC Fund
Luke Timmerman Talk to biotech VCs, and you’ll hear a lot of moaning about how tough the FDA has become, how grim the IPO markets are, and how hard it is get insurers to pay for new products. Nobody...
View ArticleClik here to view.
Biotech VCs Have a Problem, and it Will Get Worse Before It Gets Better
Luke Timmerman We’ve heard warnings for a couple of years now that the chickens would come home to roost in the biotech venture capital scene. Quite a few VCs just haven’t delivered the returns to...
View ArticleClik here to view.
Biotech Can’t Sidestep Cost-Effectiveness Anymore
Luke Timmerman Back in the old days of biotech, the business was pretty straightforward. You’d craft your scientific idea, aim a new drug at patients in need, charm investors to give you some money,...
View ArticleClik here to view.
Even With New Crowdfunding Rules, No Easy Path Forward For Biotechs
[Corrected 11/3/15, 1:18pm. See below.] As Xconomy reported Friday, the U.S. Securities and Exchange Commission has finally filled in the missing pieces in the equity crowdfunding puzzle, giving...
View ArticleClik here to view.
Dauntless Takes Flight with New Business Model for Starting Biotechs
First came Inception Sciences, a holding company for spinning out biotech startups established by Versant Ventures and Peppi Prasit, the veteran San Diego drug developer. Then came COI...
View ArticleClik here to view.
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy
When thousands of cancer researchers from around the world gather in Chicago this weekend for the American Society of Clinical Oncology’s annual meeting, drugs that fight tumors by boosting a...
View ArticleClik here to view.
Checkmate Pharma Clinches $27M for More Studies in Skin Cancer
Checkmate Pharmaceuticals believes its approach to cancer treatment can make a certain type of immunotherapy work better, and it now has $27 million in additional funding to help build that case....
View Article
